Trials / Unknown
UnknownNCT03054818
Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word（STONE）
Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (estimated)
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a post-marketing drug safety monitoring study in a prospective manner, and data collection will be performed in a registration-follow-up manner. Safety information about patients who have received intravitreal injection of Conbercept Ophthalmic Injection in medical institutions involved in the study during research will be actively monitored without intervening in diagnosis and treatment. All patients enrolled will be followed up for one year.
Conditions
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2017-02-16
- Last updated
- 2017-02-16
Locations
49 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03054818. Inclusion in this directory is not an endorsement.